Learn about LITFULO®, an FDA-approved prescription pill for treating severe alopecia areata for both adults and adolescents as young as 12. See important safety information

LITFULO (ritlecitinib) capsules are formulated with ritlecitinib tosylate, a kinase inhibitor. Ritlecitinib tosylate is a white to off white to pale pink solid which is freely soluble in water.

LITFULO is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older. (1) Limitations of Use: Not recommended for use in …

Jun 27, 2023 · Litfulo is used to treat severe alopecia areata to reduce hair loss in adults and adolescents 12 years and older. It is an oral capsule that is taken once a day. Includes Litfulo …

LITFULO® (ritlecitinib) Medication Guide This Medication Guide has been approved by the U.S. Food and Drug Administration. Issued: 6/2023 Medication Guide LITFULO™ (lit-FUL-oh) …

Nov 24, 2024 · Find patient medical information for Litfulo (ritlecitinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Litfulo works by reducing the activity of enzymes called JAK3 and TEC kinases, which are involved in inflammation at the hair follicle. This reduces the inflammation, leading to hair …

Jul 4, 2025 · Ritlecitinib is used to treat severe alopecia areata in adults and adolescents 12 years and older. It is a capsule that is taken 1 time a day. The brand name is Litfulo.

Discover LITFULO®, the only FDA-approved treatment for severe alopecia areata in both adults and adolescents as young as 12. See safety info.

Jun 23, 2023 · LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12 Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and …